Gyre Therapeutics, Inc. Common Stock (NASDAQ: GYRE) last traded at $6.91, down 1.57% on the session. The quote above updates while this page is open; the figures below are drawn from Gyre Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Gyre Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker GYRE. Its market capitalisation is $770.53 million.
Valuation measures for Gyre Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $770.53M |
|---|---|
| Enterprise value | $761.58M |
| Price / sales | 6.62 |
| Price / book | 7.14 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Gyre Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $116.42M |
|---|---|
| Net income (TTM) | -$25.67M |
| Gross margin | 87.97% |
| Operating margin | -10.53% |
| Return on equity | -23.79% |
| Cash | $43.29M |
Range and volume for GYRE over the past 52 weeks.
| 52-week high | $9.42 |
|---|---|
| 52-week low | $5.44 |
| Volume | 66.0K |
| Average volume | 86.0K |
| Previous close | $7.02 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.